Insiders Iovance Biotherapeutics, Inc.

Equities

IOVA

US4622601007

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-09 EDT			5-day change	1st Jan Change
13.45 ^USD	+0.45%		+4.43%	+65.44%

05-09	Iovance Biotherapeutics Q1 Loss Narrows -- Shares Higher After Hours	MT
05-09	Earnings Flash (IOVA) IOVANCE BIOTHERAPEUTICS Posts Q1 Revenue $715,000	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

General (Ret.) Merrill A. McPeak, Member of the Board of Directors of Iovance Biotherapeutics, Inc. Retires and Not Stands for Re-Election	03-29	CI
Iovance Biotherapeutics Insider Bought Shares Worth $45,750,000, According to a Recent SEC Filing	02-21	MT
Iovance Biotherapeutics Insider Bought Shares Worth $292,800, According to a Recent SEC Filing	02-21	MT
Iovance Biotherapeutics Insider Bought Shares Worth $2,287,500, According to a Recent SEC Filing	02-21	MT
Iovance Biotherapeutics Insider Bought Shares Worth $26,500,000, According to a Recent SEC Filing	23-09-18	MT
Iovance Biotherapeutics, Inc. Announces Wendy Dixon, Member of Board of Directors, Will Not Stand for Re-Election	23-04-26	CI
Iovance Biotherapeutics, Inc. Appoints Wendy L. Yarno as Director and New Member of the Board	23-04-24	CI
TScan Therapeutics Names Debora Barton as Chief Medical Officer	22-07-07	MT
Iovance Biotherapeutics, Inc. Appoints Wendy L. Dixon to Board of Directors	22-06-13	CI
Iovance Biotherapeutics Announces Raj K. Puri as Executive Vice President, Regulatory Strategy and Translational Medicine	22-01-10	CI
Iovance Biotherapeutics, Inc. Announces Management Changes	21-05-19	CI
Iovance Biotherapeutics, Inc. Appoints Igor Bilinsky as Chief Operating Officer	21-03-15	CI
Iovance Biotherapeutics, Inc. Announces Board Changes	21-03-11	CI
Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial Officer	20-12-14	CI
Iovance Biotherapeutics, Inc. Announces Executive Changes	20-06-12	CI
Iovance Biotherapeutics Appoints Friedrich Graf Finckenstein as Chief Medical Officer	19-07-18	CI
Iovance Biotherapeutics, Inc. Appoints Athena Countouriotis to its Board of Directors and Member of the Board’s Nominating and Corporate Governance Committee and the Compensation Committee	19-06-11	CI
Sanford J. Hillsberg Intends Not to Stand for Re-Election as Member of the Board of Directors of Iovance Biotherapeutics, Inc	18-03-14	CI
Iovance Biotherapeutics Announces Board Changes	18-03-01	CI
Iovance Biotherapeutics, Inc. Announces Executive Change	17-11-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Iovance Biotherapeutics, Inc.

Equities

IOVA

US4622601007

Insiders

Filters